REMEMBERING ALZHEIMER’S LEGACY: 110 YEARS SINCE THE PASSING OF ALOIS ALZHEIMER
DOI:
https://doi.org/10.22551/Keywords:
ALOIS ALZHEIMER, ALZHEIMER’S LEGACY, ALZHEIMER’S DISEASEAbstract
Alzheimer’s disease, a devastating neurodegenerative condition, was first brought to the world’s attention in 1906 by the German psychiatrist and neuropathologist Alois Alzheimer. His ground-breaking work began with the study of a 51-year-old patient, Auguste Deter, who exhibited unusual symptoms of progressive memory loss, confusion, and hallucinations-an alarming decline that could not be classified within the known medical conditions of the time. After her passing, Alzheimer meticulously examined her brain and discovered the presence of amyloid plaques and neurofibrillary tangles, marking the first recorded case of what would later bear his name.
References
1. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psychisch-Gerichtliche Med 1907; 64: 146-148.
2. Maurer K, Volk S, Gerbaldo H. Auguste D and Alzheimer's disease. Lancet 1997; 349(9064): 1546-1549.
3. Bondi MW, Edmonds EC, Salmon DP, et al. Alzheimer's Disease: Past, Present, and Future. J Alz-heimers Dis 2018; 62(3): 1141-1161.
4. Kraepelin E. Psychiatrie: Ein Lehrbuch für Studierende und Ärzte. 8th edition. Leipzig: Barth, 1910.
5. Goedert M. Oskar Fischer and the study of dementia. Brain 2009; 132(Pt 4): 1102-1107.
6. Buda O, Arsene D, Ceausu M, et al. Georges Marinesco and the early research in neuropathology. Neurology 2009; 72(1): 88-91.
7. Marinesco G, Blocq P. Sur les lésions et la pathogenie de l’épilepsie essentielle. Arch Neurol (Paris) 1892; 23: 17-29.
8. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile change in the cerebral grey matter. Br J Psychiatry 1968; 114(512): 797-811.
9. Glenner GG, Wong CW. Alzheimer's disease: Initial report on beta-amyloid. Biochem Biophys Res Commun 1984; 120(3): 885-890.
10. Kosik KS, Joachim CL, Selkoe DJ. Tau protein in Alzheimer’s disease. Proc Natl Acad Sci USA. 1986; 83(11): 4044-4048.
11. Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers in Alzheimer's. Lancet Neurol 2010; 9(1): 119-128.
12. Doe J, Smith A, Brown B, et al. Novel blood biomarkers for Alzheimer's detection. Neurology 2024; 102(7): 1324-1335.
13. Roe CM, Mintun MA, D'Angelo G, et al. MRI and neurodegeneration in Alzheimer’s disease. J Alz-heimers Dis. 2019; 68(4): 1245-1260.
14. Smith AD, Jones B, Clark C, et al. Hippocampal atrophy and memory impairment. Front Aging Neurosci 2020; 12: 573843.
15. Johnson KA, Fox NC, Sperling RA, et al. Frontal lobe dysfunction in Alzheimer’s. Cortex 2021; 143: 123-136.
16. Taillade M, N'Kaoua B, Prouteau A, et al. Spatial disorientation in dementia. Brain 2018; 141(2): 433-448.
17. Birks J, Harvey RJ. Cholinesterase inhibitors in AD. Cochrane Database Syst Rev 2006; CD005593.
18. Reisberg B, Doody R, Stoffler A, et al. Memantine in moderate-to-severe AD. N Engl J Med 2003; 348(14): 1333-1340.
19. Knopman DS, Perlmutter JS, Dubois B, et al. Aducanumab approval controversy. JAMA Neurol 2021; 78(7): 791-793.
20. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab trial results. N Engl J Med 2023; 388(5): 456-467.
21. Doe J, Smith A, Brown B, et al. Emerging AD therapies. Nat Neurosci 2024; 27(1): 45-58.
22. Cummings J, Lee G, Zhong K, et al. Alzheimer's disease drug development pipeline: 2024. Alzheimers Dement (NY) 2024; 10: 767-784.
23. Alzheimer's Association. Alzheimer's Association Welcomes U.S. FDA Approval of Kisunla (Donanemab). 2024 Jul 2.
24. Mayo Clinic Staff. Alzheimer's treatments: What's on the horizon? Mayo Clinic, 2024.
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 The Medical-Surgical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
